Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis

Rustgi, S. D., Oh, A., Yang, J. Y., Kang, D., Wolin, E., Kong, C. Y., Hur, C., & Kim, M. K. (2021). Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis. BMC Cancer, 21(1). https://doi.org/10.1186/s12885-021-08306-5
Authors:
Sheila D. Rustgi
Aaron Oh
Jeong Yun Yang
Dasol Kang
Edward Wolin
Chung Y. Kong
Chin Hur
Michelle K. Kim
Affiliated Authors:
Sheila D. Rustgi
Aaron Oh
Chin Hur
Columbia Affiliation:
Author Keywords:
carcinoid
cost-effectiveness analysis
neuroendocrine tumors
peptide receptor radionuclide therapy
somatostatin analogues
elink
Publication Type:
Article
Unique ID:
10.1186/s12885-021-08306-5
PMID:
34030646
DOI:
10.1186/s12885-021-08306-5
Journal:
BMC Cancer
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: